OVID - Ovid Therapeutics GAAP EPS of -$0.21 beats by $0.04 August, 09 2022 08:29 AM Ovid Therapeutics Inc. Ovid Therapeutics press release ( NASDAQ: OVID ): Q2 GAAP EPS of -$0.21 beats by $0.04 . Cash, cash equivalents and marketable securities as of June 30, 2022 was $152.4 million For further details see: Ovid Therapeutics GAAP EPS of -$0.21 beats by $0.04